Nomura Holdings
TBPH icon

Nomura Holdings’s Theravance Biopharma TBPH Stock Holding History

Nomura Holdings’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-352
Closed -$3K – 2462
2021
Q3 		$3K Buy
+352
New +$3.94K ﹤0.01% 1961
2019
Q3 		– Sell
-210,000
Closed -$3.56M – 1394
2019
Q2 		$3.56M Buy
210,000
+150,000
+250% +$3.04M 0.02% 566
2019
Q1 		$1.41M Buy
+60,000
New +$1.52M 0.01% 751
2014
Q3 		– Sell
-6,713
Closed -$215K – 3031
2014
Q2 		$215K Buy
+6,713
New +$202K ﹤0.01% 2336

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Nomura Holdings's TBPH Position: Q4 2021 in Review

Nomura Holdings sold out of Theravance Biopharma (TBPH) in Q4 2021, closing a stake of 352 shares — an estimated $3K sold.

Nomura Holdings first reported a position in TBPH in Q2 2014 and held it in 4 quarters. The position peaked at $3.56M in Q2 2019. 116 funds tracked by Wall St. Rank hold TBPH as of Q4 2021.

  • Nomura Holdings reported no remaining Theravance Biopharma position as of Q4 2021 after selling out during the quarter.
  • Nomura Holdings sold 352 Theravance Biopharma shares in Q4 2021, an estimated $3K.
  • Nomura Holdings first reported a position in Theravance Biopharma in Q2 2014 and held it in 4 quarters.
  • Nomura Holdings's Theravance Biopharma position peaked at $3.56M in Q2 2019.
  • 116 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2021.

Based on Nomura Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.